Clinical Trials
3 trialsNCT02735980 2020-03-17
A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung Cancer
Eli Lilly and Company
Phase 2 Completed
NCT02860780 2018-12-14
A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic Cancer
Eli Lilly and Company
Phase 1 Completed
NCT01115790 2016-05-10
A Phase 1 Study in Participants With Advanced Cancer
Eli Lilly and Company
Phase 1 Completed